Jeremy Levin, Ovid Therapeutics CEO (Ovid website via YouTube)

Fol­low­ing a piv­otal tri­al fail and lay­offs, Ovid finds it­self in a fa­mil­iar spot

Last week, Ovid Ther­a­peu­tics dis­closed lay­off plans in an SEC fil­ing fol­low­ing a Phase 3 flop for its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.